Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer

Lin, YT; Tsai, TH; Wu, SG; Liu, YN; Yu, CJ; Shih, JY

Shih, JY (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, 7 Zhongshan South Rd, Taipei 100, Taiwan.; Shih, JY (corresponding author), Natl Taiwan Univ, Coll Med, 7 Zhongshan South Rd, Taipei 100, Taiwan.

LUNG CANCER, 2020; 145 (): 1

Abstract

Objectives: Osimertinib is active against epidermal growth factor receptor (EGFR) T790M-mutated non-small cell lung cancer (NSCLC). However, its effic......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索